Sponsor Pipeline

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
Active Trials by Phase
Phase 4
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT02555072 Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba… Yellow Fever Vaccine Active, Not Recruiting
Phase 1
NCT06627257 Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy Leprosy Not Yet Recruiting
NCT07640308 Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus) Not Yet Recruiting
Get alerts when The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free